In vivo reflectance confocal microscopy can detect the invasive component of lentigo maligna melanoma: Prospective analysis and case–control study
Journal of the European Academy of Dermatology and Venereology · 2023-07 · 37 (7) · 1293-1301
DOI: 10.1111/jdv.18998 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 25.03.2023. Verfasst von Bruna Melhoranse Gouveia und 9 weiteren Autor:innen. Beteiligte Einrichtung: Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Hutchinson's Melanotic Freckle, Melanoma, Skin Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Melanoma Institute Australia, MetaOptima Technology Incl., Hoffmann-La Roche Ltd, Evaxion, Provectus Biopharmaceuticals Australia, Qbiotics, Novartis, Merck Sharp & Dohme, NeraCare, AMGEN I…, NHMRC Practitioner Fellowship.
Abstract (Originalsprache)
Background
Lentigo maligna (LM), a form of melanoma in situ, has no risk of causing metastasis unless dermal invasive melanoma (LMM) supervenes. Furthermore, the detection of invasion impacts prognosis and management.
Objective
To assess the accuracy of RCM for the detection of invasion component on LM/LMM lesions.
Methods
In the initial case–control study, the performance of one expert in detecting LMM at the time of initial RCM assessment of LM/LMM lesions was recorded prospectively ( n = 229). The cases were assessed on RCM‐histopathology correlation sessions and a panel with nine RCM features was proposed to identify LMM, which was subsequently tested in a subset of initial cohort ( n = 93) in the matched case–control study by two blinded observers. Univariable and multivariable logistic regression models were performed to evaluate RCM features predictive of LMM. Reproducibility of assessment of the nine RCM features was also evaluated.
Results
A total of 229 LM/LMM cases evaluated by histopathology were assessed blindly and prospectively by an expert confocalist. On histopathology, 210 were LM and 19 were LMM cases. Correct identification of an invasive component was achieved for 17 of 19 LMM cases (89%) and the absence of a dermal component was correctly diagnosed in 190 of 210 LM cases (90%). In the matched case–control (LMM n = 35, LM n = 58), epidermal and junctional disarray, large size of melanocytes and nests of melanocytes were independent predictors of LMM on multivariate analysis. The interobserver analysis demonstrated that these three features had a fair reproducibility between the two investigators ( K = 0.4). The multivariable model including those three features showed a high predictive performance AUC = 74% (CI 95% 64–85%), with sensitivity of 63% (95% CI 52–78%) and specificity of 79% (CI 95% 74–88%), and likelihood ratio of 18 ( p ‐value 0.0026).
Conclusion
Three RCM features were predictive for identifying invasive melanoma in the background of LM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
- Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
- Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
- CHUS - Hôtel-Dieu, Sherbrooke, Québec, Canada.
- Department of Dermatology, Medical University of Vienna, Vienna, Austria.
- Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia.
ORCID-Profile: Bruna Melhoranse Gouveia, Serigne N Lo, Richard A Scolyer
Förderung
- Melanoma Institute Australia
- MetaOptima Technology Incl., Hoffmann-La Roche Ltd, Evaxion, Provectus Biopharmaceuticals Australia, Qbiotics, Novartis, Merck Sharp & Dohme, NeraCare, AMGEN I…
- NHMRC Practitioner Fellowship
Zitieren
APA
Gouveia, B. M., Carlos, G., Wadell, A., Sinz, C., Ahmed, T., Lo, S. N., Rawson, R. V., Ferguson, P. M., Scolyer, R. A., & Guitera, P. (2023). In vivo reflectance confocal microscopy can detect the invasive component of lentigo maligna melanoma: Prospective analysis and case–control study. Journal of the European Academy of Dermatology and Venereology, 37(7), 1293-1301. https://doi.org/10.1111/jdv.18998
Vancouver
Gouveia BM, Carlos G, Wadell A, Sinz C, Ahmed T, Lo SN, et al. In vivo reflectance confocal microscopy can detect the invasive component of lentigo maligna melanoma: Prospective analysis and case–control study. Journal of the European Academy of Dermatology and Venereology. 2023;37(7):1293-1301. doi:10.1111/jdv.18998
BibTeX
@article{Gouveia2023,
author = {Gouveia, Bruna Melhoranse and Carlos, Giuliana and Wadell, Andreanne and Sinz, Christoph and Ahmed, Tasnia and Lo, Serigne N and Rawson, Robert V and Ferguson, Peter M and Scolyer, Richard A and Guitera, Pascale},
title = {In vivo reflectance confocal microscopy can detect the invasive component of lentigo maligna melanoma: Prospective analysis and case–control study},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2023},
volume = {37},
number = {7},
pages = {1293--1301},
doi = {10.1111/jdv.18998}
}
EUVIMED